We are pleased to announce that Acellmed has been qualified as one of the 15 start-ups to the semi-finals of the Start-up Challenge 2022 competition and will be presented during the XIV European Economic Congress on 25-27.04.2022.
We will present our company in the category HEALTH & BIOTECHNOLOGY – Medicine, health, medical technology, pharmacy, biotechnology.
We will present our project, which is an innovative drug for COVID-19 and a platform for the rapid production of drugs blocking virus-cell interactions, which, with minor modifications, may find application in other epidemics.
We invite you to the European Economic Congress in Katowice – the largest business meeting in Central Europe.
Link to Acellmed business card: